JASUF yields 8000.00% · MRK yields 2.76%● Live data
📍 JASUF pulled ahead of the other in Year 1
Combined, JASUF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JASUF + MRK for your $10,000?
Jasmine International Public Company Limited provides telecommunications services to individual and corporate clients in Thailand. The company provides high-speed connectivity; Internet services and applications; and software development, distribution, and general software services, including software system that supports value added services for broadband Internet business. It also offers marine and submarine optical fiber maintenance services; international private leased-circuit, Internet protocol virtual private network services, leased line Internet services, managed network services through optic fiber and copper cable networks, National Internet Exchange services, and co-location services and satellite communications. In addition, the company provides data center services; online movie and internet protocol television services; fixed-line services; international calling cards services; wireless communication services through very small aperture terminal; satellite phone services, and small mobile handset and fixed handset for users to use the service from a fixed indoor location in a remote area; and distributes equipment. Further, it engages in system integration, equipment sourcing, system design, and IT systems implementation for government and private sectors; cloud computing; the consultancy, design, and implementation of computer and IT network systems; the provision of space rental services; and investing in telecommunications infrastructure business, other assets, securities, and/or instruments. The company was founded in 1982 and is headquartered in Nonthaburi, Thailand.
Full JASUF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.